Literature DB >> 8786184

Proposal for a pathogenesis-based classification of tumoral calcinosis.

D Smack1, S A Norton, J E Fitzpatrick.   

Abstract

BACKGROUND: Deposition of calcium in skin is currently categorized into a group of disorders referred to as calcinosis cutis. Divisions between types and subtypes within this confusing classification are predominantly based on morphologic differences in the calcification and serve to obscure pathogenesis. This is especially evident in a subtype of calcinosis cutis, known as tumoral calcinosis. Calcifications in cases of tumoral calcinosis share the following characteristics, but without evidence of a common pathogenesis: large size, juxtaarticular location, progressive enlargement over time, a tendency to recur after surgical removal, and an ability to encase adjacent normal structures. The goal of this study was to formulate a pathogenesis-based classification for cases of tumoral calcinosis.
METHODS: In a literature review 121 cases of tumoral calcinosis were identified. These cases, along with a case evaluated in our clinic, were reviewed retrospectively, and their features compared.
RESULTS: Analysis suggests three pathogenetically distinct subtypes of tumoral calcinosis: (1) Primary normophosphatemic tumoral calcinosis: patients have normal serum phosphate, normal serum calcium, and no evidence of disorders previously associated with soft tissue calcification; (2) primary hyperphosphatemic tumoral calcinosis: patents have elevated serum phosphate, normal serum calcium, and no evidence of disorders previously associated with soft tissue calcification; and (3) secondary tumoral calcinosis: patients have a concurrent disease capable of causing soft tissue calcification. Justification for this classification is based on the presence or absence of disorders known to promote soft tissue calcification and statistically significant differences in family history, mean calcification number, mean serum phosphate level, and calcification recurrence after excision.
CONCLUSIONS: A classification for tumoral calcinosis is devised that outlines potential pathogenetic mechanisms and predicts response to therapy and prognosis. Analysis of other forms of calcinosis cutis may reveal definable pathogenetic differences that suggest a coherent classification for all cutaneous calcinoses.

Entities:  

Mesh:

Year:  1996        PMID: 8786184     DOI: 10.1111/j.1365-4362.1996.tb02999.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  40 in total

1.  Beneficial Response to Phosphate Lowering Therapy in Normophosphatemic Tumoral Calcinosis.

Authors:  Sarayu Soumya; Nandini Prasad; Puthiyaveettil Khadar Jabbar; Sajid Hussain; Chellamma Jayakumari; Abilash Nair
Journal:  Indian Pediatr       Date:  2021-01-15       Impact factor: 1.411

2.  A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification.

Authors:  Ilana Chefetz; Raoul Heller; Assimina Galli-Tsinopoulou; Gabriele Richard; Bernd Wollnik; Margarita Indelman; Friederike Koerber; Orit Topaz; Reuven Bergman; Eli Sprecher; Eckhard Schoenau
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

3.  A man with an enlarging foot mass.

Authors:  Ali Zahrai; Deloar Hossain; John M Embil; Elly Trepman
Journal:  CMAJ       Date:  2004-11-23       Impact factor: 8.262

4.  Pathomorphological features of calcinosis circumscripta in a dog.

Authors:  Eun-Mi Lee; Ah-Young Kim; Eun-Joo Lee; Kyu-Shik Jeong
Journal:  Lab Anim Res       Date:  2016-03-24

5.  A large calcified retroperitoneal mass in a patient with chronic renal failure: liposarcoma with ossification.

Authors:  Itsuko Okuda; Yoshifumi Ubara; Chikao Okuda; Takeshi Fujii; Tatsuya Suwabe; Takashi Kokubo; Yasio Nakajima; Masaji Hashimoto
Journal:  Clin Exp Nephrol       Date:  2009-10-31       Impact factor: 2.801

6.  Idiopathic tumoral calcinosis presenting in early childhood.

Authors:  Mudita Gupta; Saru Thakur; Reena Sharma; Archit Gupta
Journal:  BMJ Case Rep       Date:  2019-01-24

7.  Clinical and genetic analysis of idiopathic normophosphatemic tumoral calcinosis in 19 patients.

Authors:  Q-Y Zuo; X Cao; B-Y Liu; D Yan; Z Xin; X-H Niu; C Li; W Deng; Z-Y Dong; J-K Yang
Journal:  J Endocrinol Invest       Date:  2019-09-18       Impact factor: 4.256

8.  Tumoral Calcinosis.

Authors:  A Alam; M N Sree Ram; K Manrai; R Bhardwaj
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 9.  ASIA syndrome, calcinosis cutis and chronic kidney disease following silicone injections. A case-based review.

Authors:  Giuseppe Barilaro; Claudia Spaziani Testa; Antonella Cacciani; Giuseppe Donato; Mira Dimko; Amalia Mariotti
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

10.  Tc-MDP bone scintigraphy in a case with sporodical tumoral calcinosis.

Authors:  Tulay Kacar Guveli; Mehmet Mulazimoglu; Muge Oner Tamam; Cüneyt Tamam; Tarik Tatoglu; Tevfik Ozpacaci
Journal:  Indian J Nucl Med       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.